Navigation Links
Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding
Date:9/21/2009

In the US, one in five women suffer from heavy periods or irregular bleeding. Not only does this condition lead to discomfort and embarrassment, it also negatively impacts daily routines. Irregular menstrual bleeding is called menorrhagia. Most women with menorrhagia don't know that heavy bleeding is not normal--it is a recognized medical condition for which they can seek treatment.

Phoenix, AZ (Vocus/PRWEB) September 20, 2009. In the US, one in five women suffer from heavy periods or irregular bleeding. Not only does this condition lead to discomfort and embarrassment, it also negatively impacts daily routines. Irregular menstrual bleeding is called menorrhagia. Most women with menorrhagia don't know that heavy bleeding is not normal--it is a recognized medical condition for which they can seek treatment.

Many women are embarrassed to seek medical attention for their heavy periods, believing that bleeding heavily for 4 to 5 days or changing their pad every hour is something they have to live with. Some women worry that their treatment options may be extreme or invasive. However, more options exist now that ever before for women suffering from abnormally heavy bleeding.

The most common treatment options include endometrial ablation, hormones, dilation and curettage (D&C), and hysterectomy. While a physician will recommend the proper treatment for the specific needs of the patient, studies have shown that hormones are minimally effective. Another option, D&C, can minimize symptoms, but the results are not long-term. Lastly, hysterectomy is a major surgery with significant risks and recovery time.

Endometrial ablation has emerged as an attractive alternative for the treatment of menorrhagia. This procedure treats the lining of the uterus to control or stop bleeding. It does not involve removal of the uterus and it does not affect a woman's hormone levels.

During the procedure a lighted viewing instrument (hysteroscope) and other instruments are used to destroy (ablate) the uterine lining, or endometrium.

Because endometrial ablation destroys a thin layer of the lining of the uterus, menstrual flow stops in many women. In some women, menstrual bleeding is only reduced to normal or lighter levels. If ablation does not control heavy bleeding, further treatment or surgery may be required.

The most common methods of ablation are thermal (by laser, radiofrequency, or heated saline,) Electricity (using a special scope and a loop or roller-ball electrode,) freezing or microwave.

Endometrial ablation is usually done in an outpatient facility or hospital and, depending on the method of ablation, usually takes only a short time to complete. The procedure may be done using a local or spinal anesthesia.

DoctorFinders.com helps to disseminate information regarding the treatments for menorraghia, including endometrial ablation, through its growing website. Thousands are logging on to not only learn of the latest advancements in the medical field, but to also find a physician or surgeon who is right for them.

Contact: Riley Horlacher
Company: DoctorFinders.com
Website: www.doctorfinders.com
Phone: (877) 619-7159

# # #

Read the full story at http://www.prweb.com/releases/womens_health/endometrial_ablation/prweb2917094.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Internal radiotherapy better than external for quality of life in endometrial cancer patients
2. Global view shows link between endometrial cancer and vitamin D status
3. Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist
4. Two Endometrial Cancer Treatments May Not Work
5. Ovary Removal May Not Be Needed in Endometrial Cancer
6. Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause
7. Gene Mutation May Up Risks of Endometrial Cancer
8. Dream team targets key driver for breast, ovarian, endometrial cancers
9. New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy
10. Obesity Greatly Raises Endometrial Cancer Risk
11. New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Rassouli, dentist in ... cognitive decline. According to the research, which was published in the “Journal of the ... decline, and about 5.4 million Americans have Alzheimer’s disease. The study found that dental ...
(Date:5/2/2016)... Boston, MA (PRWEB) , ... May 02, 2016 , ... ... and tips when trying to conceive. , “If you are ready to ... Dr. Mache Seibel. “My book, HealthChequesTM: Journal Babies is your Personal Conception & ...
(Date:5/2/2016)... ... ... Kulbersh of Carolina Facial Plastics isn’t surprised that Charlotte, NC, the city where he and ... Cities with the Highest Plastic Rates .” The other cities that made the list ... a survey by RealSelf and combining that data with the number of board-certified ...
(Date:5/2/2016)... Beach, FL (PRWEB) , ... May 02, 2016 , ... ... to great pain and suffering. With no cure, most patients must deal with prescription ... a free coupon card, allowing up to 75% savings at the pharmacy on many ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... which includes amniotic fluid/“stem cells” and Platelet Rich Plasma (PRP) injections. “These are ... said Dr. James Baranski, D.C., of Advanced Spine & Sport Medical. “We are ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
(Date:4/28/2016)... 2016   Acsis , a leading provider of ... market research and advisory firm IDC has named it ... Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment ... assessment of the capabilities and business strategies of 10 ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
Breaking Medicine Technology: